FNCH Finch Therapeutics Group Inc.
17.18
-0.33 -2%
Previous Close
17.51
Open
17.35
52 Week Low
15.265
52 Week High
22.5
Market Cap
$809,958,006
Shares
47,145,402
Float
26,755,604
Enterprise Value
$727,613,989
Volume
47,035
Av. Daily Volume
120,850
Upcoming Catalysts
| Drug | Stage | Catalyst Date |
|---|---|---|
|
FIN-211
Autism Spectrum Disorder
|
Phase 1
Phase 1
|
Premium membership is required to view catalyst dates, analyst ratings, earnings dates and cash burn data. Click here to unlock and sign up to a 14-day FREE TRIAL.
|
Drug Pipeline
| Drug | Stage | Notes |
|---|---|---|
|
CP101
Hepatitis B
|
Phase 1
Phase 1
|
Phase 1b trial to commence mid-2021.
|
|
FIN-524
Ulcerative Colitis
|
Phase 1
Phase 1
|
Phase 1 trial to commence 1H 2022.
|
|
CP101
Clostridioides difficile infection
|
Phase 3
Phase 3
|
Second Phase 3 trial to commence mid-2021.
|